Lymphoma News

Time to engraftment after hematopoietic stem cell transplantation is an important outcome that institutions are legally required to report to the Center for International Blood and Marrow Transplant Research.

NEW ORLEANS — In the STOP-CA trial, prophylactic atorvastatin therapy reduced the occurrence of anthracycline-associated left ventricular dysfunction at 12 months among patients who underwent treatment for Hodgkin and non-Hodgkin lymphoma.

Survivors of blood or marrow transplants exhibited an increased risk for developing subsequent malignant neoplasms in the gastrointestinal tract, according to results of a cohort study published in JAMA Oncology.

The FDA announced several regulatory actions the past few weeks.

The economic cost of cancer worldwide from 2020 to 2050 will be $25.2 trillion in international dollars, according to results of a decision analytical modeling study published in JAMA Oncology.

Vedolizumab showed greater efficacy than placebo when added to standard prophylaxis for prevention of lower gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, according to a study.

Automatic calcium scoring with nongated chest CT was prognostic of major adverse and cardiotoxicity-related CV events in patients with large B-cell lymphoma undergoing anthracycline-based chemotherapy, researchers reported.

Only a decade ago, many in oncology considered chimeric antigen receptor T-cell therapy too fringe for real-world use.

Healio | HemOnc Today is excited to announce a new physician leadership structure, which features seven Associate Medical Editors from various subspecialty areas within oncology and hematology.

Researchers observed significant racial disparities in all-cause and CVD mortality among adults with cancer, with wider gaps found among patients younger than 55 years, according to a study published in JACC: CardioOncology.